Inventor

HAYNES BARTON F

US83 patents

⚠️ This page may combine multiple inventors who share the name “HAYNES BARTON F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAYNES BARTON F

UNIV DUKE

SCID mouse engrafted with human synovium tissue

Production of antibodies to HIV

Production of antibodies to HIV

Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domain

Method of inhibiting HIV infection with CD44 and anti-CD44 antibodies

Synthetic vaccine for protection against human immunodeficiency virus infection

Method of determining the presence and titers of anti HIV-1 ag27bodies

Adhesion molecule

Swarm immunization with envelopes from CH505

Antibody evolution immunogens

Immunogen comprising an HIV envelope protein, a ligand and H2 peptide

Anti-complement factor H antibodies

Anti-Complement factor H antibodies

Anti-CD6 ligand antibodies

HIV-1 neutralizing antibodies and uses thereof (CD4bs antibodies)

MPER-liposome conjugates and uses thereof

Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies

Immunogen comprising an HIV envelope protein, a ligand and H2 peptide

Method of inducing the production of antibodies to HIV

Assay system

Synthetic peptides

Compositions comprising HIV envelopes to induce CH235 lineage antibodies

Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects

Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects

Compositions and methods for inducing HIV-1 antibodies

Methods to identify immunogens by targeting improbable mutations

Compositions and methods for inducing HIV-1 antibodies

Bispecific molecules comprising an HIV-1 envelope targeting arm

Complement factor H antibodies

HIV-1 neutralizing antibodies and uses thereof

CD6 ligand encoding sequence

CD6 ligand

KORBER BETTE T

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Human immunodeficiency virus type 1 clade M mosaic gag polypeptides

Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins

HAYNES BARTON F

Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

Liposome-peptide conjugate and method of using same to induce production of anti-HIV antibodies

Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses

MACROGENICS INC

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

LOS ALAMOS NAT SECURITY LLC

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

UNIV CALIFORNIA

Polyvalent immunogen

Polyvalent immunogen

BETH ISRAEL HOSPITAL

Human immunodeficiency virus immunogenic composition

Immunogenic composition

UNIV CALFORINIA

Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope